Koninklijke Philips N.V. (PHG) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Devices
EV/EBITDA
↓
10.73
↓-85% vs avg
5yr avg: 70.01
30Y Low6.1·High30.1
P/FCF
↑
24.72
↑+24% vs avg
5yr avg: 19.98
30Y Low11.0·High171.2
P/B Ratio
↑
2.03
+8% vs avg
5yr avg: 1.88
30Y Low1.1·High4.0
ROE
↓
7.8%
↓+228% vs avg
5yr avg: 2.4%
30Y Low-20%·High51%
Debt/EBITDA
↓
3.17
↓-86% vs avg
5yr avg: 23.45
30Y Low0.6·High6.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PHG Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Koninklijke Philips N.V. trades at 24.9x earnings, 39% below its 5-year average of 41.2x, sitting at the 50th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 13%. On a free-cash-flow basis, the stock trades at 24.7x P/FCF, 24% above the 5-year average of 20.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $25.9B | $26.1B | $23.6B | $21.4B | $14.3B | $32.4B | $48.0B | $43.1B | $31.8B | $34.5B | $27.5B |
| Enterprise Value | $32.1B | $31.4B | $28.7B | $26.8B | $20.4B | $36.2B | $51.7B | $46.9B | $34.9B | $37.3B | $30.7B |
| P/E Ratio → | 24.95 | 29.12 | — | — | — | 53.30 | 40.76 | 36.89 | 29.22 | 20.91 | 18.99 |
| P/S Ratio | 1.24 | 1.46 | 1.31 | 1.18 | 0.80 | 1.89 | 2.77 | 2.51 | 1.75 | 1.94 | 1.12 |
| P/B Ratio | 2.03 | 2.37 | 1.96 | 1.77 | 1.07 | 2.24 | 4.03 | 3.41 | 2.62 | 2.87 | 2.03 |
| P/FCF | 24.72 | 29.19 | 17.45 | 11.05 | — | 22.24 | 22.28 | 25.43 | 33.91 | 34.17 | 26.52 |
| P/OCF | 19.00 | 22.43 | 13.92 | 9.27 | — | 16.82 | 18.19 | 18.94 | 17.85 | 18.47 | 14.42 |
P/E links to full P/E history page with 30-year chart
PHG EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Koninklijke Philips N.V.'s enterprise value stands at 10.7x EBITDA, 85% below its 5-year average of 70.0x. The Healthcare sector median is 14.1x, placing the stock at a 24% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.76 | 1.59 | 1.48 | 1.15 | 2.11 | 2.99 | 2.74 | 1.93 | 2.10 | 1.25 |
| EV / EBITDA | 10.73 | 12.30 | 14.98 | 23.41 | 280.10 | 19.27 | 22.19 | 20.66 | 12.43 | 14.68 | 9.76 |
| EV / EBIT | 19.22 | 20.71 | 62.44 | — | — | 53.73 | 30.69 | 27.27 | 20.46 | 23.02 | 22.31 |
| EV / FCF | — | 35.11 | 21.21 | 13.85 | — | 24.81 | 24.00 | 27.69 | 37.25 | 36.91 | 29.68 |
PHG Profitability
Margins and return-on-capital ratios measuring operating efficiency
Koninklijke Philips N.V. earns an operating margin of 8.0%. Operating margins have expanded from -0.6% to 8.0% over the past 3 years, signaling improving operational efficiency. ROE of 7.8% is modest. ROIC of 6.4% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.2% | 45.2% | 43.1% | 41.0% | 40.4% | 41.8% | 45.7% | 46.4% | 47.2% | 46.0% | 43.3% |
| Operating Margin | 8.0% | 8.0% | 2.9% | -0.6% | -8.6% | 3.2% | 7.3% | 8.0% | 9.5% | 8.5% | 7.7% |
| Net Profit Margin | 5.0% | 5.0% | -3.9% | -2.6% | -9.0% | 19.3% | 6.9% | 6.8% | 6.0% | 9.3% | 5.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.8% | 7.8% | -5.8% | -3.7% | -11.6% | 25.2% | 9.7% | 9.4% | 9.0% | 13.0% | 11.5% |
| ROA | 3.2% | 3.2% | -2.4% | -1.6% | -5.2% | 11.3% | 4.3% | 4.4% | 4.2% | 5.8% | 4.6% |
| ROIC | 6.4% | 6.4% | 2.3% | -0.5% | -6.1% | 2.5% | 5.9% | 6.5% | 8.6% | 7.2% | 8.7% |
| ROCE | 7.1% | 7.1% | 2.5% | -0.5% | -6.6% | 2.5% | 6.3% | 7.2% | 9.4% | 7.5% | 8.8% |
PHG Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Koninklijke Philips N.V. carries a Debt/EBITDA ratio of 3.2x, which is moderately leveraged (roughly in line with the sector average of 3.3x). Net debt stands at $5.3B ($8.1B total debt minus $2.8B cash). Interest coverage of 4.6x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.74 | 0.74 | 0.62 | 0.60 | 0.55 | 0.42 | 0.58 | 0.42 | 0.40 | 0.39 | 0.42 |
| Debt / EBITDA | 3.17 | 3.17 | 3.91 | 6.36 | 100.58 | 3.22 | 2.97 | 2.32 | 1.72 | 1.86 | 1.78 |
| Net Debt / Equity | — | 0.48 | 0.42 | 0.45 | 0.46 | 0.26 | 0.31 | 0.30 | 0.26 | 0.23 | 0.24 |
| Net Debt / EBITDA | 2.08 | 2.08 | 2.65 | 4.73 | 84.52 | 2.00 | 1.59 | 1.69 | 1.12 | 1.09 | 1.04 |
| Debt / FCF | — | 5.92 | 3.76 | 2.80 | — | 2.57 | 1.72 | 2.26 | 3.34 | 2.75 | 3.16 |
| Interest Coverage | 4.56 | 4.56 | 1.36 | -0.72 | -6.09 | 4.10 | 8.69 | 8.22 | 6.46 | 6.16 | 2.42 |
PHG Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.32x means Koninklijke Philips N.V. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.94x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 1.20x to 1.32x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | 1.32 | 1.23 | 1.20 | 1.29 | 1.39 | 1.45 | 1.36 | 1.21 | 1.47 | 1.34 |
| Quick Ratio | 0.94 | 0.94 | 0.84 | 0.78 | 0.78 | 0.93 | 1.06 | 0.96 | 0.87 | 1.13 | 1.02 |
| Cash Ratio | 0.37 | 0.37 | 0.30 | 0.23 | 0.15 | 0.31 | 0.42 | 0.20 | 0.27 | 0.28 | 0.23 |
| Asset Turnover | — | 0.66 | 0.62 | 0.62 | 0.58 | 0.55 | 0.62 | 0.63 | 0.70 | 0.70 | 0.76 |
| Inventory Turnover | 3.41 | 3.41 | 3.20 | 3.07 | 2.63 | 2.90 | 3.14 | 3.32 | 3.58 | 4.08 | 4.10 |
| Days Sales Outstanding | — | 72.25 | 74.37 | 85.40 | 95.27 | 91.23 | 87.64 | 106.84 | 84.24 | 86.30 | 83.81 |
PHG Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Koninklijke Philips N.V. returns 1.5% to shareholders annually primarily through dividends. The payout ratio of 36.6% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 4.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.5% | 1.3% | 0.0% | 0.0% | 3.0% | 1.8% | 0.0% | 1.2% | 1.3% | 1.1% | 1.2% |
| Payout Ratio | 36.6% | 36.6% | — | — | — | 17.2% | 0.1% | 43.4% | 36.8% | 23.2% | 22.8% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.0% | 3.4% | — | — | — | 1.9% | 2.5% | 2.7% | 3.4% | 4.8% | 5.3% |
| FCF Yield | 4.0% | 3.4% | 5.7% | 9.1% | — | 4.5% | 4.5% | 3.9% | 2.9% | 2.9% | 3.8% |
| Buyback Yield | 0.0% | 0.0% | 1.9% | 3.3% | 1.4% | 6.0% | 0.7% | 3.6% | 3.3% | 1.9% | 2.2% |
| Total Shareholder Yield | 1.5% | 1.3% | 1.9% | 3.4% | 4.4% | 7.7% | 0.7% | 4.8% | 4.5% | 3.0% | 3.4% |
| Shares Outstanding | — | $963M | $933M | $949M | $952M | $950M | $958M | $973M | $997M | $1.0B | $990M |
Peer Comparison
Compare PHG with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PHGYou | $26B | 24.9 | 10.7 | 24.7 | 45.2% | 8.0% | 7.8% | 6.4% | 3.2 |
 SYK | $112B | 34.8 | 20.2 | 26.1 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 BSX | $83B | 28.9 | 25.1 | 22.8 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 EW | $48B | 45.5 | 25.5 | 35.9 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 BAX | $9B | -9.7 | 25.0 | 27.1 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 |
 ZBH | $16B | 23.3 | 9.4 | 11.0 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
 MDT | $99B | 21.5 | 14.3 | 19.2 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 GE | $320B | 37.5 | 32.8 | 44.0 | 36.8% | 19.1% | 45.3% | 24.7% | 2.1 |
 GEHC | $28B | 13.6 | 10.1 | 18.6 | 40.0% | 13.4% | 21.6% | 13.3% | 3.0 |
 HAE | $2B | 15.9 | 10.2 | 17.2 | 57.2% | 16.3% | 18.8% | 10.0% | 3.7 |
 ISRG | $160B | 57.4 | 43.4 | 64.4 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Full PHG Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See PHG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PHG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PHG vs SYK
Side-by-side business, growth, and profitability comparison vs Stryker Corporation.
Start ComparisonPHG — Frequently Asked Questions
Quick answers to the most common questions about buying PHG stock.
What is Koninklijke Philips N.V.'s P/E ratio?
Koninklijke Philips N.V.'s current P/E ratio is 24.9x. The historical average is 30.9x. This places it at the 50th percentile of its historical range.
What is Koninklijke Philips N.V.'s EV/EBITDA?
Koninklijke Philips N.V.'s current EV/EBITDA is 10.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.9x.
What is Koninklijke Philips N.V.'s ROE?
Koninklijke Philips N.V.'s return on equity (ROE) is 7.8%. The historical average is 9.5%.
Is PHG stock overvalued?
Based on historical data, Koninklijke Philips N.V. is trading at a P/E of 24.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Koninklijke Philips N.V.'s dividend yield?
Koninklijke Philips N.V.'s current dividend yield is 1.47% with a payout ratio of 36.6%.
What are Koninklijke Philips N.V.'s profit margins?
Koninklijke Philips N.V. has 45.2% gross margin and 8.0% operating margin.
How much debt does Koninklijke Philips N.V. have?
Koninklijke Philips N.V.'s Debt/EBITDA ratio is 3.2x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.